Start the conversation
Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) CEO J. Michael Pearson is on medical leave, and executives will run the company during his absence. Pearson was recently hospitalized for a severe case of pneumonia. Valeant has recently been in the spotlight because of its pricing and distribution policies, and the VRX stock price is down 52.26% in the last six months.